跳至主要内容

 Compound stability is an important factor to consider during the early stages of drug discovery. We have a leading portfolio of compound stability services designed to help you understand the metabolic profile of your compounds.

The aim of metabolic stability study is measuring the disappearance rate of a chemical compound. The half-life, in vitro clearance measured from metabolic stability assay can be used to predict hepatic clearance, and also to evaluate dose, toxicity, oral bioavailability, etc. For instance, if a drug is rapidly metabolized when entering to the body, it may require more daily dosing to maintain its blood or tissue concentrations in order to get an ideal therapeutic effect. On the other hand, if a drug is slowly metabolized, the dose need to be adjusted and more preclinical toxicity tests should be conducted as long-time exposure may cause toxic build-up.

Many compounds with promising pharmacological characteristics never become drugs due to poor metabolic stability profiles. For example, a drug that is rapidly metabolized may not produce sufficient in vivo exposure levels or a drug that is slowly metabolized could remain in the body for extended periods leading to unwanted adverse effects.In order to provide accurate predictions of the stability of your compounds in various organs in the body, we offer a wide variety of in vitro test systems.All our assays can be ordered individually, combined or as a selection of key stability services provided in our drug candidate assessment packages to provide cost savings.



Liver Microsomal Stability

The liver is the main organ for drug metabolism in the body. Microsome, the liver subcellular fraction, is an important model for drug metabolism studies. It contains many drug metabolizing enzymes (like P450s, FMOs, and UGTs), easy to prepare, has long storing period, easy to adaptable to HTS, and can make donor pool from multiple donors to minimize the effect of interindividual variability. Medicilon provides liver microsomal stability assay which incubates microsomes with the test compound at 37°C followed by monitoring disappearance of the test compound. The results are characterized by UPLC/HR-MS/MS.

Hepatocyte Stability

Intact hepatocytes contain the cytochrome P450s (CYPs), non-P450 enzymes, and phase II enzymes such as sulfo- and glucuronosyltransferases. Therefore, hepatocyte assays can more broadly assess the overall cellular metabolism of the test compound than liver microsomal assay. Medicilon provides immortalized human liver cell line HepaRG for hepatocyte stability assays.

 

S9 Stability

S9 fraction (post-mitochondrial supernatant fraction) is another important model for drug metabolism studies. S9 fraction consists of both microsomal and cytosolic enzymes (SULT, GST, XO, ADHs, NATs) and it can be supplemented with cofactors such as UDPGA and PAPS to investigate Phase II metabolic pathways.

 

Recombinant Enzymes Stability

Medicilon uses mixture of expressed enzymes (e.g. CYP450s and UGTs) to identify which enzyme metabolizing isoforms are responsible for the metabolism of a test compound. Also, it is useful for identifying potential drug-drug interactions. This system is especially useful for studying highly stable compounds.

Contact Us:

Email : marketing@medicilon.com

Tel : +44 1223 981 792（Europe）

+82 (0)70-8269-5849（South Korea）

08044216898（Japan）

+86 021 58591500（China )

Website: https://www.medicilon.com

Related Articles:

Stability Studies of Pharmaceuticals

Microsatellite Instability Tied to Cancer Progression and Survival

Compound water solubility and stability test

Biopharmaceutical Stability Research Test

Excipient manufacturers pay attention to stability test

标签：

评论

发表评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...
发表评论
阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...
发表评论
阅读全文

What is Toxicokinetics?

Toxicokinetics  is essentially the study of “how a substance gets into the body and what happens to it in the body”. Four processes are involved in toxicokinetics. The study of the kinetics (movement) of chemicals was originally conducted with pharmaceuticals and thus the term pharmacokinetics became commonly used. In addition, toxicology studies were initially conducted with drugs. However, the science of toxicology has evolved to include environmental and occupational chemicals as well as drugs. Toxicokinetics is thus the appropriate term for the study of the kinetics of all toxic substances. Frequently the terms  toxicokinetics ,  pharmacokinetics , or disposition may be found in the literature to have the same meaning. Disposition is often used in place of toxicokinetics to describe the time-course of movement of chemicals through the body (that is, how does the body dispose of a xenobiotic?). The disposition of a toxicant along with its’ biological reactivi...
发表评论
阅读全文